Since 1990, Aurora has been serving the global scientific research community through the development of innovative laboratory solutions. Headquartered in Vancouver, Canada, the company started manufacturing analytical instrumentation based on a patented capacitively coupled plasma emission technology. In 2000, Aurora became the first to develop a non-radioactive, label-free technology for the study and high throughput screening of ion channel and transporter targets. This technology has been rapidly incorporated into many pharmaceutical drug discovery pipelines and academic labs. Capitalizing on this expertise in high throughput technologies, Aurora expanded its products to include the VERSA series of automated liquid handling platforms aimed at the life science, molecular diagnostics, and precision medicine fields. We are committed to improving the quality of human and environmental health by providing products and services that facilitate higher throughput while enhancing quality, accuracy, and precision.
Since 2003, Aurora been the host of the annual Precision Medicine and Ion Channel Retreat. This conference, designed to bring together industry and leading academic researchers to share knowledge, exchange ideas, and establish fruitful partnerships. This conference alternates every year between Canada and China, attracting leading scientists from around the world to engage in thought-provoking discussions on drug discovery and personalized medicine. It allows Aurora and the community to keep a pulse on cutting edge technology and innovative research.
In 2007, Aurora Biomed opened its Asia sales and services center to facilitate expansion into the rapidly growing Asia market. To further expand Aurora’s market reach, an active network of distributors based in over 80 countries worldwide, providing sales and service support to customers, was developed.
